The Latest Breaking News from AstraZeneca

Cellectis, backed by AstraZeneca funding and a multi-year cash runway, is advancing its prioritized allogeneic CAR-T pipeline toward pivotal 2025 milestones.

TRUMP TARIFFS: UK-based drug companies AstraZeneca and GSK could be affected by Trump’s next decision, as Karl Matchett reports

Government seeks ways to shield industry from possible US levies amid concern over effect on medicine supply

Donald Trump has warned tariffs on pharmaceuticals would come ‘in the not-too-distant future’

Tariffs on Britain’s pharmaceutical industry could deal a severe blow, potentially costing firms billions of pounds

The new treatment helps to slow or stop the spread of cancer cells

U-turn by medicines watchdog means about 3,000 women with advanced forms of disease could benefit each year

The Institute of Cancer Research, London, which helped develop the drug, welcomed the move.

In Uganda, motorcycles known as boda bodas are a key part of the transport system. The country has over 1.5 million boda bodas on the road, amounting to roughly 70% of all vehicles. Boda bodas are crucial in providing last mile transport for people and goods on short trips because…

The boss’s bonus is an annual debating point at Britain’s biggest company. But that’s not the only issue this year

The PA news agency looks at which sectors will be most affected by the plans and what it means for businesses and households.